RPL17 and neoplasm: Antitumor activity of BMS-986301 (intratumorally) ± anti–PD-1 (intraperitoneally) was evaluated in bilaterally implanted staged (100 mm3) CT26 or MC38 mouse tumor models; abscopal activity was measured in the noninjected distal tumor.